» Articles » PMID: 22006976

The Th17 Immune Response is Controlled by the Rel-RORγ-RORγ T Transcriptional Axis

Overview
Journal J Exp Med
Date 2011 Oct 19
PMID 22006976
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

The Th17 cells use the retinoid-related orphan receptor-γ (Rorg or Rorc) to specify their differentiation and lineage-specific function. However, how Rorg is switched on during Th17 differentiation is unknown. We report here that c-Rel and RelA/p65 transcription factors drive Th17 differentiation by binding to and activating two distinct Rorg promoters that control RORγT and RORγ expression, respectively. Similar to RORγT, RORγ is selectively expressed in Th17 cells and is effective in specifying the Th17 phenotype. T cells deficient in c-Rel or RelA are significantly compromised in Th17 differentiation, and c-Rel-deficient mice are defective in Th17 responses. Thus, Th17 immunity is controlled by a Rel-RORγ-RORγT axis, and strategies targeting Rel/NF-κB can be effective for controlling Th17 cell-mediated diseases.

Citing Articles

Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments.

Miao M, Yan J, Sun Y, Liu J, Guo S J Inflamm Res. 2025; 18:2045-2072.

PMID: 39959643 PMC: 11827491. DOI: 10.2147/JIR.S506103.


RORγt inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis.

Collins M, Pehrson R, Grindebacke H, Leffler A, Ramnegard M, Rannikmae H PLoS One. 2025; 20(1):e0317090.

PMID: 39820614 PMC: 11737796. DOI: 10.1371/journal.pone.0317090.


PCSK9 in T-cell function and the immune response.

Wang Y, Fang X, Liu J, Lv X, Lu K, Lu Y Biomark Res. 2024; 12(1):163.

PMID: 39736777 PMC: 11687167. DOI: 10.1186/s40364-024-00712-8.


The β-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner.

Hajiaghayi M, Gholizadeh F, Han E, Little S, Rahbari N, Ardila I Front Immunol. 2024; 15:1446424.

PMID: 39445009 PMC: 11496295. DOI: 10.3389/fimmu.2024.1446424.


Immune Implications of Cholesterol-Containing Lipid Nanoparticles.

Back P, Yu M, Modaresahmadi S, Hajimirzaei S, Zhang Q, Islam M ACS Nano. 2024; 18(42):28480-28501.

PMID: 39388645 PMC: 11505898. DOI: 10.1021/acsnano.4c06369.


References
1.
He Y, Deftos M, Ojala E, Bevan M . RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity. 1999; 9(6):797-806. PMC: 2776668. DOI: 10.1016/s1074-7613(00)80645-7. View

2.
Visekruna A, Huber M, Hellhund A, Bothur E, Reinhard K, Bollig N . c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur J Immunol. 2010; 40(3):671-6. DOI: 10.1002/eji.200940260. View

3.
Weaver C, Harrington L, Mangan P, Gavrieli M, Murphy K . Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006; 24(6):677-688. DOI: 10.1016/j.immuni.2006.06.002. View

4.
Zheng Y, Josefowicz S, Chaudhry A, Peng X, Forbush K, Rudensky A . Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010; 463(7282):808-12. PMC: 2884187. DOI: 10.1038/nature08750. View

5.
Pui J, Allman D, Xu L, DeRocco S, Karnell F, Bakkour S . Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 1999; 11(3):299-308. DOI: 10.1016/s1074-7613(00)80105-3. View